AAP
CNMD icon

Arax Advisory Partners’s CONMED CNMD Stock Holding History

Arax Advisory Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6K Buy
+781
New +$28.1K ﹤0.01% 3787
2025
Q4 		– Sell
-32
Closed -$1.5K – 4165
2025
Q3 		$1.5K Buy
32
+6
+23% +$311 ﹤0.01% 3165
2025
Q2 		$1.35K Buy
26
+20
+333% +$1.1K ﹤0.01% 2680
2025
Q1 		$363 Sell
6
-73
-92% -$4.71K ﹤0.01% 2560
2024
Q4 		$5.41K Hold
79
– – ﹤0.01% 1715
2024
Q3 		$5.68K Hold
79
– – ﹤0.01% 1657
2024
Q2 		$5.48K Buy
+79
New +$5.76K ﹤0.01% 1557

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Arax Advisory Partners's CNMD Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in CONMED (CNMD) in Q2 2026: 781 shares worth $25.6K. The stake represents ﹤0.01% of the portfolio and ranks #3787 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in CNMD as recently as Q3 2025.

Arax Advisory Partners first reported a position in CNMD in Q2 2024 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Arax Advisory Partners held 781 shares of CONMED worth $25.6K as of Q2 2026.
  • CONMED was a new Arax Advisory Partners position in Q2 2026.
  • CONMED made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3787 holding.
  • Arax Advisory Partners first reported a position in CONMED in Q2 2024 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.